These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 7556391

  • 1. Antithrombotic effect of a humanized anti-GPIIb/IIIa monoclonal antibody, YM207, in a photochemically induced thrombosis model in monkeys.
    Kaku S, Kawasaki T, Sakai Y, Taniuchi Y, Yano S, Suzuki K, Terazaki C, Kawamura K, Masuho Y, Satoh N.
    Eur J Pharmacol; 1995 Jun 12; 279(2-3):115-21. PubMed ID: 7556391
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
    Kaku S, Kawasaki T, Hisamichi N, Sakai Y, Taniuchi Y, Inagaki O, Yano S, Suzuki K, Terazaki C, Masuho Y, Satoh N, Takenaka T, Yanagi K, Ohshima N.
    Thromb Haemost; 1996 Apr 12; 75(4):679-84. PubMed ID: 8743199
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM, Wu CC, Ko FN, Lee FY, Kuo SC.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):161-6. PubMed ID: 9059849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
    Kawano KI, Hokamura K, Kondo K, Ikeda Y, Suzuki Y, Umemura K.
    Eur J Pharmacol; 2001 Apr 13; 417(3):217-22. PubMed ID: 11334853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombotic effect of Z4A5 on coronary thrombosis in a canine model of acute unstable angina.
    Jing BB, Li YX, Zhang H, Ren ST, Wang M, Li YP, Shen XL, Wang YL, Zang WJ, Wang B.
    Br J Pharmacol; 2013 Jun 13; 169(4):848-59. PubMed ID: 23083032
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK.
    Circulation; 1994 Jan 13; 89(1):3-12. PubMed ID: 8281661
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.
    Mickelson JK, Simpson PJ, Lucchesi BR.
    J Mol Cell Cardiol; 1989 Apr 13; 21(4):393-405. PubMed ID: 2746660
    [Abstract] [Full Text] [Related]

  • 18. Effect of a humanized monoclonal antibody to von Willebrand factor in a canine model of coronary arterial thrombosis.
    Kageyama S, Matsushita J, Yamamoto H.
    Eur J Pharmacol; 2002 May 17; 443(1-3):143-9. PubMed ID: 12044804
    [Abstract] [Full Text] [Related]

  • 19. Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.
    Mousa SA, DeGrado WF, Mu DX, Kapil RP, Lucchesi BR, Reilly TM.
    Circulation; 1996 Feb 01; 93(3):537-43. PubMed ID: 8565173
    [Abstract] [Full Text] [Related]

  • 20. Improved Antithrombotic Activity and Diminished Bleeding Side Effect of a PEGylated αIIbβ3 Antagonist, Disintegrin.
    Kuo YJ, Chang YT, Chung CH, Chuang WJ, Huang TF.
    Toxins (Basel); 2020 Jun 28; 12(7):. PubMed ID: 32605221
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.